Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis.

Mohan M, Lin C, Guest E, Shilatifard A.

Nat Rev Cancer. 2010 Oct;10(10):721-8. doi: 10.1038/nrc2915. Epub 2010 Sep 16. Review.

PMID:
20844554
2.

The super elongation complex (SEC) family in transcriptional control.

Luo Z, Lin C, Shilatifard A.

Nat Rev Mol Cell Biol. 2012 Sep;13(9):543-7. doi: 10.1038/nrm3417. Epub 2012 Aug 16. Review.

PMID:
22895430
3.

The super elongation complex (SEC) and MLL in development and disease.

Smith E, Lin C, Shilatifard A.

Genes Dev. 2011 Apr 1;25(7):661-72. doi: 10.1101/gad.2015411. Review.

4.

The molecular biology of mixed lineage leukemia.

Slany RK.

Haematologica. 2009 Jul;94(7):984-93. doi: 10.3324/haematol.2008.002436. Epub 2009 Jun 16. Review.

5.

Mixed lineage leukemia: roles in human malignancies and potential therapy.

Marschalek R.

FEBS J. 2010 Apr;277(8):1822-31. doi: 10.1111/j.1742-4658.2010.07608.x. Epub 2010 Mar 4. Review.

6.

The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis.

Daser A, Rabbitts TH.

Semin Cancer Biol. 2005 Jun;15(3):175-88. Review.

PMID:
15826832
7.

Molecular pathogenesis of MLL-associated leukemias.

Eguchi M, Eguchi-Ishimae M, Greaves M.

Int J Hematol. 2005 Jul;82(1):9-20. Review.

PMID:
16105754
8.

Therapeutic targeting of MLL.

Liedtke M, Cleary ML.

Blood. 2009 Jun 11;113(24):6061-8. doi: 10.1182/blood-2008-12-197061. Epub 2009 Mar 16. Review.

9.

The biological and clinical significance of MLL abnormalities in haematological malignancies.

Mitterbauer-Hohendanner G, Mannhalter C.

Eur J Clin Invest. 2004 Aug;34 Suppl 2:12-24. Review.

PMID:
15291802
10.

MLL translocations, histone modifications and leukaemia stem-cell development.

Krivtsov AV, Armstrong SA.

Nat Rev Cancer. 2007 Nov;7(11):823-33. Review.

PMID:
17957188
11.

Rearrangements involving chromosome band 11Q23 in acute leukaemia.

Rowley JD.

Semin Cancer Biol. 1993 Dec;4(6):377-85. Review.

PMID:
8142623
12.

The pathogenesis of mixed-lineage leukemia.

Muntean AG, Hess JL.

Annu Rev Pathol. 2012;7:283-301. doi: 10.1146/annurev-pathol-011811-132434. Epub 2011 Oct 17. Review.

13.

Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.

Sanjuan-Pla A, Bueno C, Prieto C, Acha P, Stam RW, Marschalek R, Menéndez P.

Blood. 2015 Dec 17;126(25):2676-85. doi: 10.1182/blood-2015-09-667378. Epub 2015 Oct 13. Review.

14.

Mixed lineage rearranged leukaemia: pathogenesis and targeting DOT1L.

Stein EM, Tallman MS.

Curr Opin Hematol. 2015 Mar;22(2):92-6. doi: 10.1097/MOH.0000000000000123. Review.

PMID:
25635757
15.

Collaboration of MLLT1/ENL, Polycomb and ATM for transcription and genome integrity.

Ui A, Yasui A.

Nucleus. 2016 Apr 25;7(2):138-45. doi: 10.1080/19491034.2016.1177681. Review.

16.

Disordered epigenetic regulation in MLL-related leukemia.

Zhang Y, Chen A, Yan XM, Huang G.

Int J Hematol. 2012 Oct;96(4):428-37. doi: 10.1007/s12185-012-1180-0. Epub 2012 Sep 29. Review.

PMID:
23054645
17.

Chromosomal translocations involving the MLL gene: molecular mechanisms.

Aplan PD.

DNA Repair (Amst). 2006 Sep 8;5(9-10):1265-72. Epub 2006 Jun 21. Review.

18.

MLL fusions: pathways to leukemia.

Liu H, Cheng EH, Hsieh JJ.

Cancer Biol Ther. 2009 Jul;8(13):1204-11. Review.

19.

Molecular mechanisms of MLL-associated leukemia.

Yokoyama A.

Int J Hematol. 2015 Apr;101(4):352-61. doi: 10.1007/s12185-015-1774-4. Epub 2015 Mar 17. Review.

PMID:
25773519

Supplemental Content

Support Center